@wann Noone can say. The biggest things are:
- J&J will be the "growth" stock - more new product, biotech, etc. J&J however will also retain the significant anchor of the talc lawsuits in US and Canada.
- Kenvue will be the "value" stock - expect a continuation of J&J's dividend, selling...